Synthesis and antimicrobial evaluation of some new 2-(2-(p-chlorophenyl) benzimidazol-1-yl methyl)-5-substituted amino-[1,2,4]-thiadiazoles

Objective & Hypothesis:Some 2-(2-(p-chlorophenyl)benzimidazol-1-ylmethyl)-5-substituted amino-[1,3,4]-thiadiazoles were synthesized and their in vitro antimicrobial activities were tested against Staphylococcus aureus, Bacillus subtilis, Escherichia coli, Candida albicans and Candida krusei.

📊

Key Findings & Data:Compounds 1b and 12b which possess remarkable activity against C. albicans and marginal activity against C. krusei were found to be the most active compounds in this series.

💡

Conclusion & Impact:Single crystal X-ray diffraction analysis was performed for compound 8b.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

Some 2-(2-(p-chlorophenyl)benzimidazol-1-ylmethyl)-5-substituted amino-[1,3,4]-thiadiazoles were synthesized and their in vitro antimicrobial activities were tested against Staphylococcus aureus, Bacillus subtilis, Escherichia coli, Candida albicans and Candida krusei. Compounds 1b and 12b which possess remarkable activity against C. albicans and marginal activity against C. krusei were found to be the most active compounds in this series. Single crystal X-ray diffraction analysis was performed for compound 8b.

🔖

Cite This Article

ALTANLAR, N., ÖZBEY, S., KILCIGİL, A. G., KUŞ, C. (2022). Synthesis and antimicrobial evaluation of some new 2-(2-(p-chlorophenyl) benzimidazol-1-yl methyl)-5-substituted amino-[1,2,4]-thiadiazoles. Turkish Journal of Chemistry, Cilt: 29 - Sayı: 2, 153–162. https://ajindex.com/articles/602213

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

A.E. Abdel-Rahman, A.M. Mahmoud, G.M. El-Naggar and H.A. El-Sherief, Pharmazie, 38, 589-590 (1983). 2.F.S.G. Soliman, S.M. Rida, E.A.M. Badawey and T. Kappe, Arch. Pharm., 317, 951-958 (1984). 3.R.A. Coburn, M.T. Clark, R.T. Evans and R.J. Genco, J. Med. Chem., 30, 205-208 (1987). 4.N.S. Habib, S. Abdel-Hamid, M and El-Hawash, Farmaco, 44, 1225-1232 (1989). 5.H. Göker, M. Tunçbilek, G. Ayhan and N. Altanlar, Farmaco, 53, 415-420 (1998). 6.G.A. Kılcıgil, M. Tunçbilek, N. Altanlar and H. Göker, Farmaco, 54, 562-565 (1999). 7.V.L. Khairnar, S.R. Lockhande, M.R. Patel and B.G. Khadse, Bull. Haffkine Inst. 8 (1980) 67-70: Chemical Abstract, 95, 203833h (1981). 8.L.I. Kruse, D.L. Ladd, P.B. Harrsch, F.L. McCabe, S.M. Mong, L. Faucette and R. Johnson, J. Med. Chem.,32, 409-417(1989). 9.I. Islam, E.B. Skibo, R.T. Dorr and D.S. Alberts, J. Med. Chem., 34, 2954-2961 (1991). 10.V.J. Habernickel, Drugs made in Germany, 35, 97 (1992). 11.T. Fukuda, Y. Morimoto, R. Iemura, T. Kawashima, G. Tsukamoto and K. Ito, Arzneim.-Forsch./Drug Res., 34, 801-805 (1984). 12.T. Fukuda, T. Saito, S. Tajima, K. Shimohara and K. Ito, Arzneim.-Forsch./Drug Res., 34, 805-810 (1984). 13.H. Nakano, T. Inoue, N. Kawasaki, H. Miyataka, H. Matsumoto, T. Taguchi, N. Inagaki, H. Nagai and T.Satoh, Chem. Pharm. Bull., 47, 1573-1578 (1999). 14.H. Nakano, T. Inoue, N. Kawasaki, H. Miyataka, H. Matsumoto, T. Taguchi, N. Inagaki, H. Nagai and T.Satoh, Bioorg. Med. Chem., 8, 373-380 (2000). 15.B. Can-Eke, M.O. Püsküllü, E. Buyukbingol and M. Iscan, Chemico-Biological Interactions, 113, 65-77 (1998). 16.S. Demirayak, U. Abu Mohsen and A.C. Karaburun, Eur. J. Med. Chem., 37, 255-260 (2002). 17.S. Ersan, S. Nacak, N. Noyanalpan and E. Yesilada, Arzneim.-Forsch./Drug Res., 47, 834-836 (1997). 18.D.H. Boschelli, D.T. Connor, D.A. Bornemeier, R.D. Dyer, J.A. Kennedy, P.J. Kuipers, G.C. Okonkwo, D.J.Schrier and CD. Wright, J. Med. Chem., 36, 1802- 1810 (1993). 19.G. Şahin, E. Palaska, P. Kelicen, R. Demirdamar and G. Altmok, Arzneim.-Forsch./Drug Res., 51, 478-484 (2001). 20.A. Tsotinis, A. Varvaresou, T. Calogeropoulou, T. Siatra-Papastaikoudi and A. Tiligada, Arzneim.-Forsch./Drug Res., 47, 307-310 (1997). 21.A.C.T. North, D.C. Phillips and F.S. Mathews, Açta Cryst., A24, 351-359 (1968). 22.G.M. Sheldrick, SHELXS97 Program for Crystal Structure Solution, University of Göttingen, Germany (1997). 23.G.M. Sheldrick, SHELXL97 Program for Crystal Structure Refinement, University of Göttingen,Germany (1997). 2